The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...
Basel, April 30, 2014 - Novartis today announced positive first results from the Phase III head-to-head LANTERN study, which showed the superiority of once-daily ...
ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here’s what you need to know to work out if you need to pass your puffer back. Two brands have ...
Novartis’ Ultibro Breezhaler is more effective in patients at risk of chronic obstructive pulmonary disease (COPD) flare-ups than GlaxoSmithKline’s rival drug, Seretide, according to new data. The ...
Glenmark Pharmaceuticals today said it has received three observations from the US health regulator for its Pithampur, Indore plant. (Source: website) Glenmark Pharmaceuticals has entered into an ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
GlaxoSmithKline said yesterday its combination asthma drug Seretide had become the first drug to reduce the risk of death in patients with chronic obstructive pulmonary disease (COPD). GlaxoSmithKline ...
This study has demonstrated that doubling the dose of Seretide™ administered via the Diskus™ inhaler over a short period is safe and well tolerated. Whilst this is not a recommended treatment approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results